{"id":"https://openalex.org/W2440322604","doi":null,"title":"Attenuation of dermal toxicity of doxorubicin by liposome encapsulation.","display_name":"Attenuation of dermal toxicity of doxorubicin by liposome encapsulation.","publication_year":1983,"publication_date":"1983-05-01","ids":{"openalex":"https://openalex.org/W2440322604","mag":"2440322604","pmid":"https://pubmed.ncbi.nlm.nih.gov/6850663"},"language":"en","primary_location":{"id":"pmid:6850663","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6850663","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer treatment reports","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011753550","display_name":"Forssen Ea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E A Forssen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000412391","display_name":"T\u00f6k\u00e9s Za","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z A T\u00f6kes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3097,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.57872784,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"67","issue":"5","first_page":"481","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.5327000021934509,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.5327000021934509,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.39649999141693115,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.02319999970495701,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":1.0},{"id":"https://openalex.org/keywords/liposome-encapsulation","display_name":"liposome encapsulation","score":0.8360000252723694},{"id":"https://openalex.org/keywords/skin-toxicity","display_name":"skin toxicity","score":0.949999988079071},{"id":"https://openalex.org/keywords/extravasation","display_name":"extravasation","score":0.859000027179718},{"id":"https://openalex.org/keywords/anionic-liposomes","display_name":"anionic liposomes","score":0.8169999718666077},{"id":"https://openalex.org/keywords/intradermal-injection","display_name":"intradermal injection","score":0.8199999928474426},{"id":"https://openalex.org/keywords/tissue-fluorescence","display_name":"tissue fluorescence","score":0.46399998664855957},{"id":"https://openalex.org/keywords/drug-disposition","display_name":"drug disposition","score":0.8629999756813049},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7200000286102295},{"id":"https://openalex.org/keywords/chemotherapy-side-effects","display_name":"chemotherapy side effects","score":0.4580000042915344}],"concepts":[{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.9308891296386719},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.8008533716201782},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7777599096298218},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.7386112809181213},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6796852946281433},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5839002728462219},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.517171323299408},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3999503254890442},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20664361119270325},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.17361143231391907},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11904308199882507}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007271","descriptor_name":"Injections, Intradermal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:6850663","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6850663","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer treatment reports","raw_type":"Journal Article"},{"id":"mag:2440322604","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6850663","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1584196055","https://openalex.org/W1989219500","https://openalex.org/W2021555497","https://openalex.org/W2110316435","https://openalex.org/W2093442802","https://openalex.org/W2009978424","https://openalex.org/W1965437869","https://openalex.org/W2510411383","https://openalex.org/W2121298692","https://openalex.org/W1551030083"],"abstract_inverted_index":{"The":[0,92],"severe":[1],"tissue":[2],"damage":[3],"which":[4],"occurs":[5],"when":[6],"doxorubicin":[7],"(Dxn)":[8],"is":[9],"extravasated":[10],"during":[11],"infusion":[12],"has":[13],"been":[14],"attenuated":[15],"by":[16,105,111],"encapsulating":[17],"the":[18,36,45,79,82,89,96,112,125],"drug":[19,49,116],"in":[20,35,117],"anionic":[21],"liposomes.":[22],"Mice":[23],"were":[24],"injected":[25],"intradermally":[26],"with":[27],"either":[28],"0.05":[29],"or":[30,38],"0.10":[31],"mg":[32],"of":[33,58,69,81,99,108,115],"Dxn":[34,75,100],"free":[37,48,74],"liposome-entrapped":[39,90],"form.":[40],"At":[41],"both":[42],"dose":[43],"levels,":[44],"animals":[46,65],"receiving":[47,66],"developed":[50],"dermal":[51,83,97],"lesions":[52],"at":[53],"a":[54,59],"higher":[55],"frequency":[56],"and":[57],"greater":[60],"severity":[61],"than":[62,87,110],"did":[63],"those":[64],"Dxn-liposomes.":[67],"Determination":[68],"tissue-associated":[70],"fluorescence":[71],"indicated":[72],"that":[73,95],"was":[76,88,121],"removed":[77],"from":[78],"area":[80],"injection":[84],"more":[85,104],"rapidly":[86],"drug.":[91],"data":[93],"suggest":[94],"toxicity":[98],"may":[101],"be":[102],"determined":[103],"its":[106],"mode":[107],"disposition":[109],"absolute":[113],"amount":[114],"tissue.":[118],"Similar":[119],"observation":[120],"made":[122],"earlier":[123],"for":[124],"Dxn-induced":[126],"chronic":[127],"cardiotoxicity.":[128]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}